Andrew Hull insider trades

Open-market stock purchases and sales by Andrew Hull, Director at InMed Pharmaceuticals Inc, from SEC Form 4 filings since Dec 16, 2020.

Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +249%.

Recent trades

DateStockTradeValue
Dec 19, 2025INM InMed Pharmaceuticals IncBought (not open market)—
Dec 15, 2025INM InMed Pharmaceuticals IncSold (not open market)—

Companies traded

  • INM InMed Pharmaceuticals Inc: 1 buy, last Dec 19, 2025

Get free alerts when Andrew Hull files a new trade →